The Integrity of Prospectively Grading Patients
While I’ve blogged on this topic before, a recent e-mail from a patient who was turned down by our office as a “GOOD” candidate for the Regenexx-C procedure makes me want to add another chapter. Again, we look at all of the data in advance of seeing the patient and do discourage patients from coming if we think we can’t help. I think the e-mail from the patient says it all:
Thank you very much for your assistance. Please pass on my comments and questions to Dr. Schultz.
I was afraid that I would not be considered a good candidate. However, I must say that I am extremely impressed by the integrity of the evaluation and that you would essentially recommend against the likelihood of success as contrasted with simply selling a procedure. At this point, having now attempted to deal with this through conservative, non-invasive methods for 18 months without success, I am not overly interested in another approach that does not have a fairly high probability of success. So, THANK YOU VERY MUCH for your integrity.
Chris Centeno, MD
is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.
Get Blog Updates by Email